Thiazolyl-dihydro-cyclopentapyrazole

US7517995B2 · kind B2 · utility

Assignee

• Boehringer Ingelheim International GmbH · DE

Inventors

• Steffen Breitfelder · Aßmannshardt, DE
• Udo Maier · Senden, DE
• Christoph Hoenke · Ingelheim am Rhein, DE
• Anne T. Joergensen · Copenhagen, DK
• Alexander Pautsch · Ulm, DE
• Trixi Brandl · Warthausen, DE
• Matthias Grauert · Ingelheim am Rhein, DE
• Matthias Hoffmann · Mittelbiberach, DE
• Stefan Scheuerer · Warthausen, DE
• Klaus Erb · Mittelbiberach, DE
• Michael Pieper · Biberach, DE
• Ingo Pragst · Marburg, DE

Key dates

• Filing date: Mar 23, 2007
• Grant date: Apr 14, 2009
• Expiry date: Mar 23, 2027

Classification

• Technology area (CPC A): Human Necessities
• CPC primary: A61P43/00
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

Disclosed are compounds of general formula (I),wherein the groups R1, R2, Ra and Rb have the meanings given in the claims and specification, the tautomers, racemates, enantiomers, diastereomers and the mixtures thereof, and optionally the pharmacologically acceptable acid addition salts, solvates and hydrates thereof, and processes for preparing these thiazolyl-dihydro-cyclopentapyrazoles and the use thereof as pharmaceutical compositions.